Zydus Lifesciences recalls 1,116 boxes of Fulvestrant Injection in US market

05 Sep 2022 Evaluate

Zydus Lifesciences is recalling products in the US, the world's largest market for medicines, due to manufacturing issues. As per the Enforcement Report by US Food and Drug Administration (USFDA), the company is recalling 1,116 boxes of Fulvestrant Injection, a drug used to treat breast cancer.

According to the USFDA, the company's US-based unit is recalling the affected lot due to Failed Impurities/Degradation Specifications. The affected lot has been manufactured in India and has been distributed in the US by New Jersey-based Zydus Pharmaceuticals (USA). Zydus initiated the Class II voluntary recall on July 15 this year.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

881.10 13.30 (1.53%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×